BackVaxcyte Overview

Vaxcyte Other Current Assets

Vaxcyte's other current assets is $66M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$65.83M
21.35% YoYΔ $11.58M vs prior year quarter

Peer average / median

Loading

Vaxcyte Other Current Assets History

Loading

Vaxcyte vs. peers: Other Current Assets Comparison

Loading

Vaxcyte Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vaxcyte (PCVX) FAQ

As of the most recent data (June 2026), PCVX shows a other current assets of $66M. That compares with $54M in the prior-year period — up 21.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCVX's other current assets is now $66M (was $54M) — a 21.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Vaxcyte is outperforming or lagging.

Tracking PCVX's other current assets over time shows whether Vaxcyte is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $54M in the prior-year period — up 21.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Vaxcyte's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $66M) with ownership activity and broader fundamentals.

Vaxcyte's other current assets is $66M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.